Cargando…

Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Suo, Chen, Yu-Lan, Liu, Cui-Lian, Xie, Jing-Yi, Sun, Bao-Dong, Liu, Dong-Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852326/
https://www.ncbi.nlm.nih.gov/pubmed/35185871
http://dx.doi.org/10.3389/fimmu.2022.757802
_version_ 1784653019800928256
author Zhang, Suo
Chen, Yu-Lan
Liu, Cui-Lian
Xie, Jing-Yi
Sun, Bao-Dong
Liu, Dong-Zhou
author_facet Zhang, Suo
Chen, Yu-Lan
Liu, Cui-Lian
Xie, Jing-Yi
Sun, Bao-Dong
Liu, Dong-Zhou
author_sort Zhang, Suo
collection PubMed
description Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1γ antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors’ knowledge, this is the first case study describing a patient with anti-TIF1γ antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1γ-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1γ-positive dermatomyositis.
format Online
Article
Text
id pubmed-8852326
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88523262022-02-18 Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis Zhang, Suo Chen, Yu-Lan Liu, Cui-Lian Xie, Jing-Yi Sun, Bao-Dong Liu, Dong-Zhou Front Immunol Immunology Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1γ antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors’ knowledge, this is the first case study describing a patient with anti-TIF1γ antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1γ-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1γ-positive dermatomyositis. Frontiers Media S.A. 2022-02-03 /pmc/articles/PMC8852326/ /pubmed/35185871 http://dx.doi.org/10.3389/fimmu.2022.757802 Text en Copyright © 2022 Zhang, Chen, Liu, Xie, Sun and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Zhang, Suo
Chen, Yu-Lan
Liu, Cui-Lian
Xie, Jing-Yi
Sun, Bao-Dong
Liu, Dong-Zhou
Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
title Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
title_full Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
title_fullStr Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
title_full_unstemmed Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
title_short Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
title_sort case report: iga nephropathy in a patient with anti-transcription intermediary factor-1γ antibody-positive dermatomyositis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852326/
https://www.ncbi.nlm.nih.gov/pubmed/35185871
http://dx.doi.org/10.3389/fimmu.2022.757802
work_keys_str_mv AT zhangsuo casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis
AT chenyulan casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis
AT liucuilian casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis
AT xiejingyi casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis
AT sunbaodong casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis
AT liudongzhou casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis